Kiromic's Unattributed Round

Kiromic raised a round of funding on October 23, 2013.

Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. …

Articles about Kiromic's Unattributed Round: